# SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer

> **NCT00002651** · PHASE3 · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 3040 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** bicalutamide
- **DRUG:** goserelin acetate
- **OTHER:** clinical observation

## Key facts

- **NCT ID:** NCT00002651
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-05
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 3040 (ACTUAL)
- **Last updated:** 2017-04-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002651, "SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00002651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*